Genentech aren't looking for drug candidates, they're looking for a new approach to drug discovery. They have seen something in the technologies on offer which is of interest. On the basis of their past collaboration, Genentech have entered into the new agreement with eyes wide open.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.010(0.72%) |
Mkt cap ! $822.3M | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.41 | $1.35 | $146.0K | 105.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 4869 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.41 | 1669 | 3 |
View Market Depth
| Last trade - 11.19am 22/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |